Evidence map›Paper›PMID 34036261›Full record

ReviewMaterials today. Bio2021

Recent developments in bio-scaffold materials as delivery strategies for therapeutics for endometrium regeneration.

X Li, H-F Lv, R Zhao, M-F Ying, A T Samuriwo, Y-Z Zhao

Open access · goldAbstract readReview
In one paragraph

Review in Materials today. Bio, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
14.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 114 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Hysteroscopic adhesiolysis and fertility outcomes of intrauterine adhesions due to endometrial tuberculosis.Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2025
    Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

X LiDepartment of Pharmacy, Xiasha Campus, Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University (Hangzhou Xiasha Hospital), Hangzhou 310018, China.
H-F LvSchool of Pharmacy, Hangzhou Medical College, Hangzhou 310053, China.
R ZhaoDepartment of Pharmacy, Xiasha Campus, Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University (Hangzhou Xiasha Hospital), Hangzhou 310018, China.
M-F YingDepartment of Pharmacy, Xiasha Campus, Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University (Hangzhou Xiasha Hospital), Hangzhou 310018, China.
A T SamuriwoSchool of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou 325035, China.
Y-Z ZhaoSchool of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou 325035, China.
Sir Run Run Shaw Hospital · CNWenzhou Medical University · CNHangzhou Medical College · CNZhejiang University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Intrauterine adhesions (IUAs) refer to the repair disorder after endometrial injury and may lead to uterine infertility, recurrent miscarriage, abnormal menstrual bleeding, and other obstetric complications. It is a pressing public health issue among women of childbearing age. Presently, there are limited clinical treatments for IUA, and there is no sufficient evidence that these treatment modalities can effectively promote regeneration after severe endometrial injury or improve pregnancy outcome. The inhibitory pathological micro-environment is the main factor hindering the repair of endometrial damaged tissues. To address this, tissue engineering and regenerative medicine have been achieving promising developments. Particularly, biomaterials have been used to load stem cells or therapeutic factors or construct an

Indexed as

Asherman's syndrome/endometrium regenerationbFGF, basic fibroblast growth factorsBiological scaffold materialBMNCs, autologous bone marrow mononuclear cellsBMSCs, bone marrow mesenchymal stem cellsD&C, Dilatation and curettagedEMSCs, endometrial stromal cellsECM, extracellular matrixEn-PSC, endometrial perivascular cellshESCs, human embryonic stem cellsIUA, Intrauterine adhesionsKGF, Keratinocyte growth factorMSC-Sec, Mesenchymal stem cell-secretomeScaffold-based therapeutics delivery systemsSDF-1α, stromal cell-derived factor-1αStem cellTherapeutic factorUCMSCs, umbilical cord derived mesenchymal stem cellsVEGF, vascular endothelial growth factor

Identifiers

PMID34036261
PMCPMC8138682
OpenAlexW3131221168

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.